Author: Michael

CAR T-cell therapy – Novartis and the question of ‘how much?’

How much? I imagine that question came up eventually at one of the meetings of whichever team decides pricing strategies at Novartis.  And they came up with an answer: 475000 $. Four Hundred And Seventy Five Thousand dollars for a one shot therapy that can potentially cure a rare type of cancer, acute lymphoblastic leukemia (ALL). In other words,…

Want to share this?
By Michael October 29, 2017 0

CAR-T therapy against ALL  

CAR-T therapy against ALL The game  Kill the cancer with chimeric antigen receptor T-cell therapy. A cancer therapy based on genetic manipulation of T-cells to attack specific targets that would otherwise evade the immune system.  The players   T-cells   The potential cancer killer. Cells of the adaptive immune system that are responsible for killing foreign invaders…

Want to share this?
By Michael October 28, 2017 0

Difficult times – or what’s the Ivory Embassy and why?

We live in difficult times, my friends. Our society seems to have taken a collective dive into the unknown. We are ruled by prejudice and divisive leaders, experts are decried and white nationalists are grazing freely on our once so welcoming meadows. People decided to talk louder and listen less. Minds and opinions are bend…

Want to share this?
By Michael October 28, 2017 0